With an even-tempered communication style and experience as a research pharmacist, Constantine (“Dino”) Koutsoubas helps generic pharmaceutical manufacturers bring their products to market.
Dino’s litigation practice includes defending generic pharmaceutical manufacturers in matters involving pharmaceutical products liability and Hatch-Waxman patent litigation. His strong advocacy for his clients—in and out of court—and his analytical skills allow him to identify arguments and position each of his cases for the best chance of succeeding. An avid team player, Dino strives to maximize his client’s time and resources at every turn.
Prior to law school, Dino held a process engineering and research pharmacist role at a major pharmaceutical company, where he was responsible for scaling-up solid dosage form formulations from the clinical scale to the commercial scale validation batches. For his products, he was ultimately responsible for preparing the process development reports for the New Drug Application.
Dino also advises companies on emerging technologies, including cryptocurrency and non-fungible tokens. His experience includes the minting of NFTs and advising on contractual rights associated with digital assets.
Otsuka Pharm. Co., Ltd. v. Lupin Limited et al., 14–7105 (JBS) (KMW) (D.N.J.) (aripiprazole tablets)
Endo Pharms. Solutions Inc. et al. v. Paddock Laboratories, LLC et al., No. 14–01422 (D. Del.) (SLR) (testosterone undecanoate injection)
Kowa Co. Ltd. et al. v. Lupin Limited et al., 15–3935 (PAC) (S.D.N.Y.) (pitavastatin calcium tablets)
AstraZeneca AB et al. v. Lupin Limited et al., 15–6092 (MLC) (TJB) (D.N.J.) (esomeprazole magnesium delayed-release capsules)
Forest Labs., LLC v. Lupin Limited et al., 14–1058 (D. Del.) (memantine HCl extended-release capsules)
Fresenius Kabi USA, LLC et al. v. Mylan Laboratories Limited et al., 15–942 (LPS) (D. Del.) (ropivacaine HCl injection)
Shire, LLC v. CorePharma, LLC, 14–05694 (RMB) (JS) (D.N.J.) (mixed amphetamine salts extended-release capsules)
UCB, Inc. v. CorePharma, LLC, 14–01788 (RMB) (KMW) (D.N.J.) (methylphenidate HCl extended-release capsules)
Spectrum Pharms., Inc. et al. v. InnoPharma, Inc. et al., 12–260 (RGA) (CJB) (D. Del.) (levoleucovorin injection)
AstraZeneca Pharms. LP et al. v. Lupin Limited et al., 12–6888 (JAP) (TJB) (D.N.J.) (quetiapine fumarate extended-release tablets)
Merck Sharp & Dohm Corp. et al. v. Mylan Pharms., Inc., 09–6383 & 10–3085 (JLL) (MAH) (D.N.J.) (ezetimibe & ezetimibe/simvastatin)
Schering Corp. v. Glenmark Pharms., Inc., USA, 07–1334 (JLL) (ES) (D.N.J.) (ezetimibe)
Orexo AB v. Mylan Pharms., Inc.I11–3788 (FLW) (LHG) (D.N.J.) (zolpidem tartrate sublingual tablets)
Other Patent Cases
Hudson Surgical Design, Inc. v. DePuy Orthopaedics, Inc., No. 10–463 (JD) (CAN) (N.D. Ind.) (knee implant technology)
ArcelorMittal v. AK Steel et al., No. 2011–1638 (Fed. Cir.) (cold-rolled steel)
Alma Lasers, Ltd. v. Thermage, Inc., No. 07–224 (GMS) (D. Del.) (cosmetic lasers)
BorgWarner, Inc. et al v. Hilite Int’l, Inc. et al., No. 07–3339 (N.D. Ill.) (variable camshaft timing)
Hochstein v. Microsoft Corp., No. 04–73071 (PDB) (DAS) (E.D. Mich.), No. 2010–1551 (Fed. Cir.) (video game console)
Hydronics, Inc. v. Pfizer, Inc., AAA Case No. 54 193 Y 00936 08 (animal vaccine)
Lineage Power Corp. v. SynQor, Inc., No. 08–0095 (TJW) (CE) (E.D. Tex.) (power converters)
Dino was selected as one of Illinois Super Lawyers “Rising Stars,” 2015-2019.
Hellenic Bar Association, director and judicial evaluation committee member